Attenuation of cysteamine-induced duodenal ulcer with Cochinchina momordica seed extract through inhibiting cytoplasmic phospholipase A2/5-lipoxygenase and activating γ-glutamylcysteine synthetase

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue SUPPL.3, 2012, Pages 13-22

  Choi, Ki Seok ^a   Kim, Eun Hee ^a   Hong, Hua ^a   Ock, Chan Young ^a   Lee, Jeong Sang ^a   Kim, Joo Hyun ^b   Hahm, Ki Baik ^a  

^a Gachon University College of Medicine   (South Korea)

^b SK Chemicals   (South Korea)

Author keywords

Cochinchina momordica seed extract; Cysteamine; Duodenal ulcer; Glutathione

Indexed keywords

ANTIINFLAMMATORY AGENT; ARACHIDONATE 5 LIPOXYGENASE; CYCLOOXYGENASE 2; GASTRIN; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MERCAPTAMINE; MOMORDICA COCHINCHINENSIS SEED EXTRACT; PHOSPHOLIPASE A2; PLANT EXTRACT; PROTECTIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DUODENUM ULCER; ELECTRON SPIN RESONANCE; ENZYME ACTIVATION; ENZYME INHIBITION; GASTRIN BLOOD LEVEL; GENE EXPRESSION; MALE; MOMORDICA COCHINCHINENSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 84859397416     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2012.07065.x     Document Type: Article

References (24)

1. Holle GE. Pathophysiology and modern treatment of ulcer disease. Int. J. Mol. Med. 2010; 25: 483-91.
2. Hunt RH, Malfertheiner P, Yeomans ND, Hawkey CJ, Howden CW. Critical issues in the pathophysiology and management of peptic ulcer disease. Eur. J. Gastroenterol. Hepatol. 1995; 7: 685-99.
3. Laine L, Takeuchi K, Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology 2008; 135: 41-60.
4. Szabo S, Pihan G. Development and significance of cysteamine and propionitrile models of duodenal ulcer. Chronobiol. Int. 1987; 4: 31-42.
5. Jeitner TM, Lawrence DA. Mechanisms for the cytotoxicity of cysteamine. Toxicol. Sci. 2001; 63: 57-64.
6. Khomenko T, Szabo S, Deng X, Ishikawa H, Anderson GJ, McLaren GD. Role of iron in the pathogenesis of cysteamine-induced duodenal ulceration in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2009; 296: G1277-86.
7. Kirkegaard P, Poulsen SS, Loud FB, Halse C, Christiansen J. Cysteamine-induced duodenal ulcer and acid secretion in the rat. Scand. J. Gastroenterol. 1980; 15: 621-4.
8. Kang JM, Kim N, Kim B etal. Enhancement of gastric ulcer healing and angiogenesis by Cochinchina Momordica seed extract in rats. J. Korean Med. Sci. 2010; 25: 875-81.
9. Song X, Hu S. Adjuvant activities of saponins from traditional Chinese medicinal herbs. Vaccine 2009; 27: 4883-90.
10. Kudo I, Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat. 2002; 68-69: 3-58.
11. Linkous A, Yazlovitskaya E. Cytosolic phospholipase A2 as a mediator of disease pathogenesis. Cell. Microbiol. 2010; 12: 1369-77.
12. Modlin IM, Kidd M, Marks IN, Tang LH. The pivotal role of John S. Edkins in the discovery of gastrin. World J. Surg. 1997; 21: 226-34.
13. Khomenko T, Deng X, Jadus MR, Szabo S. Effect of cysteamine on redox-sensitive thiol-containing proteins in the duodenal mucosa. Biochem. Biophys. Res. Commun. 2003; 309: 910-16.
14. Szabo S, Deng X, Khomenko T etal. New molecular mechanisms of duodenal ulceration. Ann. N. Y. Acad. Sci. 2007; 1113: 238-55.
15. Khomenko T, Deng X, Sandor Z, Tarnawski AS, Szabo S. Cysteamine alters redox state, HIF-1alpha transcriptional interactions and reduces duodenal mucosal oxygenation: novel insight into the mechanisms of duodenal ulceration. Biochem. Biophys. Res. Commun. 2004; 317: 121-7.
16. Khomenko T, Szabo S, Deng X etal. Suppression of early growth response factor-1 with egr-1 antisense oligodeoxynucleotide aggravates experimental duodenal ulcers. Am. J. Physiol. Gastrointest. Liver Physiol. 2006; 290: G1211-18.
17. Romano M, Razandi M, Raza A, Szabo S, Ivey J. Cysteamine protects gastric epithelial cell monolayers against drug induced damage: evidence for direct cellular protection by sulphydryl compounds. Gut 1992; 33: 30-8.
18. Magrioti V, Kokotos G. Phospholipase A2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases. Expert Opin. Ther. Pat. 2010; 20: 1-18.
19. Deacon K, Knox AJ. Endothelin-1 (ET-1) increases the expression of remodeling genes in vascular smooth muscle through linked calcium and cAMP pathways: role of a phospholipase A(2)(cPLA(2))/cyclooxygenase-2 (COX-2)/prostacyclin receptor-dependent autocrine loop. J. Biol. Chem. 2010; 285: 25913-27.
20. Lu SC. Regulation of glutathione synthesis. Mol. Aspects Med. 2009; 30: 42-59.
21. Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol. Aspects Med. 2009; 30: 1-12.
22. Franco R, Schoneveld OJ, Pappa A, Panayiotidis MI. The central role of glutathione in the pathophysiology of human diseases. Arch. Physiol. Biochem. 2007; 113: 234-58.
23. Gao XM. Mu Bie Zi (Semen momordicae). In: Gao XM, ed. Chinese Materia Medicia. Beijing: Traditional Chinese Materia Medica Press, 2005; 601-2.
24. Kang JM, Kim N, Kim B etal. Gastroprotective action of Cochinchina momordica seed extract is mediated by activation of CGRP and inhibition of cPLA(2)/5-LOX pathway. Dig. Dis. Sci. 2009; 54: 2549-60.